Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)

External Validation of the MEESSI Acute Heart Failure Risk Score

(2019) Desiree Wussler et al.   ANNALS OF INTERNAL MEDICINE

Current and future cardiovascular disease risk assessment in the European Union: an international comparative study

(2018) Teresa J Mossakowska et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease

(2018) Lotte Kaasenbrood et al.   HEART

Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults

(2018) Anum Saeed et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The challenge of risk prediction: How good are we?

(2018) Lale Tokgozoglu et al.   European Journal of Preventive Cardiology

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials

(2018) Xavier Rossello et al.   Clinical Research in Cardiology

1149Development and validation of a decision-support tool for individualizing lifelong lipid, blood-pressure, and aspirin treatment in people without cardiovascular disease

(2018) N E M Jaspers et al.   EUROPEAN HEART JOURNAL

Smoking cessation after nurse-coordinated referral to a comprehensive lifestyle programme in patients with coronary artery disease: a substudy of the RESPONSE-2 trial

(2018) Marjolein Snaterse et al.   European Journal of Cardiovascular Nursing

Utilidad de la escala MEESSI para la estratificación del riesgo de pacientes con insuficiencia cardiaca aguda en servicios de urgencias

(2018) Òscar Miró et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART‐REACH Model

(2018) Lotte Kaasenbrood et al.   Journal of the American Heart Association

Predictors of all‐cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry

(2018) Xavier Rossello et al.   CLINICAL CARDIOLOGY

Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus

(2018) Gijs F N Berkelmans et al.   EUROPEAN HEART JOURNAL

Factors associated with confidence in decision making and satisfaction with risk communication among patients with atrial fibrillation

(2017) Berith Hedberg et al.   European Journal of Cardiovascular Nursing

Secondary prevention of cardiovascular disease: Unmet medical need, implementation and innovation

(2017) Diederick E Grobbee et al.   European Journal of Preventive Cardiology

Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort

(2017) Xinyang Hua et al.   European Journal of Preventive Cardiology

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients

(2017) Manon C. Stam‐Slob et al.   Journal of the American Heart Association

Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationClinical Perspective

(2016) Lotte Kaasenbrood et al.   CIRCULATION

Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients

(2016) Manon C. Stam-Slob et al.   Clinical Research in Cardiology

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes

(2016) Joep van der Leeuw et al.   DIABETOLOGIA

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) Massimo F. Piepoli et al.   EUROPEAN HEART JOURNAL

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

(2016) Dena Ettehad et al.   LANCET

Perceived determinants of cardiovascular risk management in primary care: disconnections between patient behaviours, practice organisation and healthcare system

(2015) E. Huntink et al.   BMC Family Practice

Long-Term Use of Cardiovascular Drugs

(2015) Xavier Rossello et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular risk estimation in older persons: SCORE O.P.

(2015) Marie Therese Cooney et al.   European Journal of Preventive Cardiology

A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys

(2015) Kaveh Hajifathalian et al.   Lancet Diabetes & Endocrinology

The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus

(2014) J van der Leeuw et al.   HEART

Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial

(2014) Angel A Lopez-Gonzalez et al.   European Journal of Preventive Cardiology

High-Dose Statin Therapy in Patients With Stable Coronary Artery Disease

(2013) Johannes A.N. Dorresteijn et al.   CIRCULATION

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

(2013) David C. Goff et al.   CIRCULATION

Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score

(2013) Johannes A N Dorresteijn et al.   HEART

Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians

(2012) Benjamin Shillinglaw et al.   BMC HEALTH SERVICES RESEARCH

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

(2012) Stuart J. Pocock et al.   EUROPEAN HEART JOURNAL

Risk prediction models: II. External validation, model updating, and impact assessment

(2012) Karel G M Moons et al.   HEART

Predictive accuracy of risk factors and markers: a simulation study of the effect of novel markers on different performance measures for logistic regression models

(2012) Peter C. Austin et al.   STATISTICS IN MEDICINE

Contemporary model for cardiovascular risk prediction in people with type 2 diabetes

(2011) Andre Pascal Kengne et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Index Event Bias as an Explanation for the Paradoxes of Recurrence Risk Research

(2011) Issa J. Dahabreh   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cardiovascular Risk-Estimation Systems in Primary Prevention

(2010) Marie Therese Cooney et al.   CIRCULATION

Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation

(2010) Massimo Francesco Piepoli et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Absolute Cardiovascular Disease Risk and Shared Decision Making in Primary Care: A Randomized Controlled Trial

(2008) T. Krones et al.   ANNALS OF FAMILY MEDICINE